Pharmacokinetics of Posaconazole Given as a Single Intravenous Dose to Obese Subjects: Dosing Obese With Noxafil® Under a Trial (DONUT)
Phase of Trial: Phase IV
Latest Information Update: 16 Apr 2019
Price : $35 *
At a glance
- Drugs Posaconazole (Primary)
- Indications Candidiasis; Chagas disease; Invasive bronchopulmonary aspergillosis; Mycoses; Oropharyngeal candidiasis
- Focus Pharmacokinetics
- Acronyms DONUT
- 16 Apr 2019 Results (n=24) presented at the 29th European Congress of Clinical Microbiology and Infectious Diseases.
- 20 Sep 2018 Status changed from recruiting to completed.
- 14 Nov 2017 Status changed from not yet recruiting to recruiting.